Boost for MDxHealth's Urology Diagnostics Tests - Orange County Business Journal
MDxHealth SA, a maker of noninvasive urology tests used to diagnose prostate cancer that’s struggled to gain traction as a public company (Nasdaq: MDXH), looks closer to turning an important corner.